leadf
logo-loader
viewFutura Medical PLC

Futura Medical CEO talks regulatory timeline and commercial potential for breakthrough gel

Futura Medical PLC's (LON:FUM)  James Barder caught up with Proactive London's Andrew Scott on the back of their 2019 results.

He says the EU filing for MED3000 is likely by the end of July, with the US Food & Drug Administration submission expected by the end of the third quarter.

MED3000 is Futura's fast-acting gel for erectile dysfunction.

Quick facts: Futura Medical PLC

Price: 15 GBX

AIM:FUM
Market: AIM
Market Cap: £36.84 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Futura Medical PLC named herein, including the promotion by the Company of Futura Medical PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Market report: FTSE falters as US Federal Reserve decision takes centre stage

The FTSE 100 mixed this Wednesday after the (OECD) said the global economy is set to shrink 4.5% in 2020, which is not as bad as the 6% collapse it had forecast in June. Also today - the UK’s inflation fell to 0.2% in August, from 1% in July - due largely to the ‘Eat out to help out’ government...

6 days, 18 hours ago

2 min read